Mukka Proteins Limited share price

Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; frozen surimi and exports seafood. It also provides insect meal, oil, and compost; humic acid, and briquettes. The company's products are used for aqua feed, poultry feed, pet feed, EPA-DHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exports its products to Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. The company was formerly known as Mukka Sea Food Industries Limited and changed its name to Mukka Proteins Limited in August …Read more

Website NSE हिंदी में BSE

Consumer DefensivePackaged FoodsNSE: MUKKAISIN INE0CG401037

16 Oct 2026, 3:29 PM IST₹27.91▼ 0.95 (3.29%)

Market Cap₹ 837 Cr.
Current Price₹ 27.91
High / Low₹ 33 / 18
Stock P/E12.1
Book Value₹ 17
Dividend Yield0.00 %
ROCE19.2 %
ROE11.10 %
Face Value₹ 1.0

More figures (10)

EPS (TTM)₹ 2.31
Price / Book1.67
OPM7.2 %
Debt / Equity1.56
Sales growth (3Y)6.7 %
Profit growth (3Y)5.7 %
Promoter holding74.5 %
EV / EBITDA10.7
Beta0.62
All-time high₹ 57

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
MUKKA	-5.49%	+20.98%	+19.32%	+16.19%	+11.64%	—	—
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Mukka Proteins Limited is in the Packaged Foods industry (Consumer Defensive), with a market value of ₹837 crore.
It trades at 12.1 times its last 12 months' earnings and 1.7 times book value.
Revenue grew 6.7% a year over the last 3 years, profit 5.7% a year.
Return on equity was 11.1% and return on capital employed 19.2% in the latest year.
Debt was 1.56 times shareholders' equity.
The share price is 16.2% below its 52-week high and up 11.6% over one year.
Promoters and insiders hold about 74.5%; institutions about 0.0%.

Pros

Latest quarter (Jun 2026): sales up 187% and profit up 1,073% from a year ago.
Healthy return on equity of 16.0% on average over the last 3 years.
Trades at 12.1 times earnings, below its 3-year median of 15.2.
Promoters hold a large stake of 73.33%.

Cons

Borrowings are high at 1.56 times shareholders' equity.
Institutional (FII + DII) holding has fallen by 6.6 points over 11 quarters.
The company has not paid a dividend recently.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Mukka Proteins Limited

Employees: 358
Head office: Mangalore

Consumer DefensivePackaged Foods

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Mukka Proteins	27.91	12.1	837	0.00	19	1,072.69	490	186.73	19.2	11.1	1.67	7.2	1.56	74.52	1,449	6.7
2.	Nestlé India	1,265.50	59.8	2,44,028	0.94	959	—	6,363	—	—	—	42.21	—	—	62.77	—	17.0
3.	Britannia Industries	4,764.00	44.1	1,14,750	1.87	591	5.61	4,964	13.46	61.2	53.5	22.47	17.0	0.27	51.18	18,858	5.7
4.	Tata Consumer Products	978.90	59.3	96,882	1.01	427	23.82	5,349	16.05	8.3	7.4	4.45	10.8	0.13	34.37	20,171	13.9
5.	Patanjali Foods	367.30	20.3	39,966	1.11	336	-6.36	11,337	19.19	11.2	14.8	3.05	3.8	0.21	69.50	40,142	8.7
6.	AWL Agri Business	187.30	21.0	24,196	0.52	350	84.09	20,048	9.98	15.3	10.5	2.32	2.5	0.78	69.18	74,619	8.7
7.	Milky Mist Dairy Food	303.85	126.1	23,392	0.00	65	—	973	—	15.5	32.1	42.15	8.3	3.62	85.52	3,120	31.0
8.	Zydus Wellness	512.75	86.6	16,314	0.24	119	-30.83	1,430	57.03	3.4	3.4	2.80	9.0	0.55	69.85	3,940	20.7
9.	LT Foods	417.65	22.6	14,503	0.95	183	14.28	3,152	41.44	18.4	14.9	3.21	8.4	0.36	61.61	10,894	16.5
10.	CCL Products (India)	1,008.30	29.1	13,445	0.53	117	14.74	1,200	43.62	20.5	18.0	5.73	11.4	0.56	49.14	4,457	29.1
	Median: 18 Co.	465.20	25.9	11,645	0.46	260	14.51	4,058	30.32	15.5	14.8	3.05	8.4	0.55	65.98	10,894	8.7

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	517	257	172	149	303	382	171	245	653	381	490
YOY Sales Growth %					-41.36%	48.65%	-1.00%	63.94%	115.57%	-0.25%	186.73%
	498	225	158	140	262	352	156	224	608	347	442
Material Cost %	88%	75%	76%	75%	73%	82%	76%	77%	84%	79%	78%
Employee Cost %	2%	3%	4%	6%	3%	2%	5%	4%	2%	3%	3%
Other Expenses %	7%	10%	12%	13%	11%	8%	11%	11%	7%	9%	9%
Operating Profit	19	32	14	10	41	29	15	21	45	34	48
OPM %	4%	13%	8%	6%	14%	8%	9%	8%	7%	9%	10%
Other Income	6	5	3	3	6	4	3	6	5	15	2
Interest	6	7	8	9	11	10	11	13	15	15	16
Depreciation	3	3	3	4	4	3	3	4	4	5	5
Profit before tax	16	27	6	0	32	20	3	10	32	29	28
	34%	-8%	5%	-187%	19%	30%	27%	25%	23%	26%	31%
Current tax	4	-1	-1	1	6	7	1	2	0	9	6
Deferred tax	1	-1	1	-2	-0	-1	-0	0	7	-2	3
	12	29	5	1	27	14	2	7	27	21	19
Profit from associates	2		-0	1	1	-0	-0	-0	3	0	-1
Minority share	2	2	1	-1	1	0	0	1	4	1	-0
Profit to shareholders	10	27	4	2	26	14	2	6	24	21	19
YOY Profit Growth %					122.03%	-51.98%	-69.77%	367.82%	1.69%	52.58%	1,072.69%
EPS in Rs	0.48	1.20	0.14	0.07	0.88	0.45	0.05	0.20	0.79	0.69	0.63
Raw filing

₹ Cr	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	484	231	148	126	287	325	136	222	558	313	406
YOY Sales Growth %					-40.67%	40.97%	-8.51%	76.28%	94.56%	-3.82%	198.88%
	472	208	139	119	250	302	125	208	526	284	364
Material Cost %	89%	78%	77%	76%	75%	82%	76%	81%	86%	79%	80%
Employee Cost %	1%	2%	4%	4%	2%	2%	4%	3%	1%	2%	2%
Other Expenses %	7%	10%	13%	14%	10%	9%	13%	10%	7%	9%	8%
Operating Profit	12	23	9	7	37	23	11	14	33	29	42
OPM %	2%	10%	6%	6%	13%	7%	8%	6%	6%	9%	10%
Other Income	8	4	3	3	6	4	3	6	6	14	2
Interest	5	7	7	8	10	9	10	12	14	14	15
Depreciation	1	1	2	2	1	1	1	1	2	3	2
Profit before tax	13	18	3	1	31	17	2	6	23	27	27
	31%	-25%	26%	-77%	21%	23%	29%	37%	25%	29%	29%
Current tax	3	-3			7	5	1	2	6	10	6
Deferred tax	1	-1	1	-0	-0	-1	-0	0	0	-2	3
	9	22	1	2	25	13	1	4	19	19	19
Profit from associates			-1	1	0	-0	-0	-0	1
YOY Profit Growth %					177.40%	-41.35%	-13.87%	66.11%	-25.27%	44.48%	1,609.87%
EPS in Rs	0.41	0.99	0.04	0.07	0.84	0.43	0.04	0.12	0.63	0.64	0.66
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2024	Mar 2025	Mar 2026	TTM
	1,380	1,006	1,449	1,768
YOY Sales Growth %		-27.06%	44.02%
	1,274	912	1,335	1,620
Material Cost %	82%	77%	81%	80%
Employee Cost %	2%	3%	3%	3%
Other Expenses %	8%	10%	9%	8%
Operating Profit	105	95	115	148
OPM %	8%	9%	8%	8%
Other Income	19	15	29	28
Interest	25	37	54	59
Depreciation	12	14	17	18
Profit before tax	87	59	73	99
	15%	21%	25%	26%
Current tax	15	12	20
Deferred tax	-1	0	-2
	74	48	57	74
Profit from associates		1	2	2
Minority share	4	2	5	5
Profit to shareholders	70	46	52	69
YOY Profit Growth %		-35.27%	18.69%
EPS in Rs	3.10	1.55	1.74	2.31

Compounded Sales Growth

TTM:: 76%

Compounded Profit Growth

TTM:: 69%

Stock Price CAGR

1 Year:: 12%

Return on Equity

4 Years:: 19%
Last Year:: 11%

₹ Cr	Mar 2024	Mar 2025	Mar 2026	TTM
	1,269	887	1,229	1,499
YOY Sales Growth %		-30.10%	38.62%
	1,187	811	1,143	1,382
Material Cost %	84%	78%	82%	82%
Employee Cost %	2%	2%	2%	2%
Other Expenses %	8%	11%	9%	8%
Operating Profit	81	76	86	118
OPM %	6%	9%	7%	8%
Other Income	20	16	29	27
Interest	24	34	50	54
Depreciation	6	6	7	8
Profit before tax	72	52	59	83
	12%	21%	28%	29%
Current tax	10	11	18
Deferred tax	-1	-0	-2
	63	42	42	61
Profit from associates		0		1
YOY Profit Growth %		-33.58%	1.75%
EPS in Rs	2.78	1.39	1.43	2.05

Compounded Sales Growth

TTM:: 72%

Compounded Profit Growth

TTM:: 46%

Stock Price CAGR

1 Year:: 12%

Return on Equity

4 Years:: 19%
Last Year:: 11%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	22	30	30	30
Reserves	126	366	411	469
	262	365	453	779
Long term borrowings	5	6	3	32
Short term borrowings	249	356	448	736
	166	179	183	343
Trade payables	131	136	142	241
Minority interest	8	12	16	30
Current liabilities	403	521	610	1,049
Total Liabilities	575	941	1,076	1,621
	84	87	102	234
Gross block	131	145	174	338
Accumulated depreciation	47	59	73	105
Goodwill & intangibles	0	0	7	14
CWIP	1	3	16	55
	490	851	959	1,332
Inventories	230	423	564	857
Trade receivables	113	185	200	182
Cash & equivalents	27	94	3	13
Current assets	464	817	926	1,289
Total Assets	575	941	1,076	1,621

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-56	-150	-112	-111
Profit for the year	44	70	46	52
Working capital changes	-128	-234	-202	-233
Direct taxes paid	-11	-26	-3	-15
	-3	-48	-35	-146
Fixed assets purchased	-8	-16	-20	-121
Fixed assets sold	0	1	2	2
	75	266	56	267
Interest paid	-11	-19	-26	-53
Net Cash Flow	15	68	-91	10
Free Cash Flow	-65	-166	-132	-232

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	29.8%	25.8%	11.1%	11.1%
ROCE	45.0%	25.4%	18.6%	19.2%
Operating margin	6.9%	7.0%	8.3%	7.2%
Net margin	3.8%	5.2%	4.7%	3.7%
Debt / equity	1.77	0.92	1.03	1.56
Current ratio	1.15	1.57	1.52	1.23
Debtor days	36	50	74	47
Inventory days	85	132	258	259
Days payable	48	43	65	73
Cash conversion cycle	73	139	267	233
Working capital days	19	80	117	62

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 73.33%
FIIs 1.70%
DIIs 0.20%
Public 24.77%

%	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%
	6.46%	5.08%	2.82%	2.63%	2.63%	2.08%	1.70%	1.70%	1.70%	1.73%	1.70%
Foreign portfolio investors (Cat. I)	6.46%	5.08%	1.93%	2.46%	2.46%	2.08%	1.70%	1.70%	1.70%	1.73%	1.70%
Foreign portfolio investors (Cat. II)			0.88%	0.17%	0.17%
	2.00%	2.50%	2.00%	1.98%	1.98%	1.87%	1.66%	0.17%			0.20%
Alternative investment funds	1.99%	2.48%	1.98%	1.98%	1.98%	1.87%	1.66%	0.17%			0.20%
	18.20%	19.09%	21.85%	22.06%	22.05%	22.71%	23.31%	24.80%	24.97%	24.93%	24.77%
Retail (up to ₹2 lakh)	17.31%	17.45%	18.95%	19.07%	19.50%	21.01%	21.61%	22.56%	22.40%	21.91%	21.46%
HNIs (above ₹2 lakh)	0.07%	0.09%	0.36%	0.36%	0.35%	0.54%	0.57%	1.10%	1.31%	1.59%	1.75%
NRIs	0.18%	0.20%	0.28%	0.37%	0.37%	0.38%	0.38%	0.40%	0.52%	0.51%	0.57%
Bodies corporate	0.20%	0.75%	1.81%	1.80%	1.31%	0.26%	0.24%	0.22%	0.22%	0.32%	0.29%
No. of Shareholders	1,15,928	1,12,093	1,44,549	1,46,062	1,47,308	1,45,343	1,41,649	1,37,920	1,32,098	1,27,922	1,24,299

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 1 Jan 1970
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Mukka Proteins Limited

What is the share price of Mukka Proteins Limited today?

Mukka Proteins Limited (MUKKA) last traded at ₹27.91 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Mukka Proteins Limited?

About ₹837 crore at the latest price.

What is the P/E ratio of Mukka Proteins Limited?

About 12.1 times its earnings over the last 12 months.

Is Mukka Proteins Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Mukka Proteins Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Mukka Proteins Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Mukka Proteins Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Mukka Proteins Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next